3D Bio

3DBio Therapeutics is a clinical-stage regenerative medicine company based in Long Island City, New York, pioneering the implantation of 3D-bioprinted living tissues in patients using cells derived from the patient's own body. The company's four-part technology platform comprises its proprietary 3D bioprinter (GMPrint), bio-ink (ColVivo), specialized cell culture processes, and implantable protective shells that together produce personalized, patient-matched tissue implants. Its lead product, AuriNovo, uses a small biopsy from a patient's ear remnant to bioprint a fully-shaped ear for surgical implantation, and is currently in clinical trials for adults and children with microtia.